Navigation Links
provides in Biological Technology

ThermoGenesis Provides Update on Fiscal 2009 Results

RANCHO CORDOVA, Calif., Aug. 6 /PRNewswire-FirstCall/ -- ThermoGenesis Corp. (Nasdaq: KOOL ), a leading supplier of innovative products for processing and storing adult stem cells, said today that it expects revenues for the fiscal year ended June 30, 2009, will be in the range of...

GeoVax Labs, Inc. Provides Clinical Studies Update

ATLANTA, Aug. 5 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), an Atlanta-based HIV/AIDS vaccine development company, today announced updates on its ongoing and planned human clinical trials. "We have two main areas of focus for our HIV/AIDS vaccine - ...

Poniard Pharmaceuticals Reports Second Quarter 2009 Financial Results and Provides a Corporate Update

SOUTH SAN FRANCISCO, Calif., Aug. 4 /PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc. (Nasdaq: PARD ), a biopharmaceutical company focused on oncology, today reported financial results for the second quarter ended June 30, 2009, and provided a corporate update. "Duri...

Revised: Sinovac Provides Update on Clinical Trial for H1N1 Vaccine Trials

BEIJING, Aug. 4 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NYSE AMEX: SVA ), a leading provider of vaccines in China, announced today that the clinical trial of its A/H1N1 influenza vaccine is proceeding well. All of the volunteers received their first shot of the vaccine and, during the thr...

Sinovac Provides Update on Clinical Trial for H1N1 Vaccine Trials

BEIJING, Aug. 3 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NYSE AMEX: SVA ), a leading provider of vaccines in China, announced today that the clinical trial of its A/H1N1 influenza vaccine is proceeding well. All of the volunteers have received their first shot of the vaccine and, during th...

Cardium Provides Update on Phase 2b Excellarate Clinical Study and Plans for Additional Tissue Repair Applications

SAN DIEGO, Calif., July 28 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Amex: CXM ) and its subsidiary Tissue Repair Company (TRC) today provided an update on the completion of their MATRIX Phase 2b clinical study and announced plans to provide detailed safety and efficacy...

Viral Genetics Retires Nearly $3.5 Million Convertible Debt and Provides Updates on Capital Structure and Stock Issuances

SAN MARINO, Calif., July 13 /PRNewswire-FirstCall/ -- Viral Genetics (Pink Sheets: VRAL), a biotechnology company that develops drug compounds for HIV/AIDS, autoimmune diseases, and cancer, has retired the majority of its $3.5 million of convertible debt. The company also retired other ...

China Clean Energy Provides Business Update

FUQING CITY, China, July 7 /PRNewswire-Asia-FirstCall/ -- China Clean Energy Inc. (OTC Bulletin Board: CCGY) ("China Clean Energy", the "Company"), a producer of biodiesel fuel and environmentally-friendly specialty chemical products made from renewable resources in The People's Republic of Ch...

MEDS World, LLC Provides Multiple Environments with Designed Solutions - Wherever People Congregate, MEDS Odor Elimination Solutions Offer Eco-Friendly, Odor-Free Air

In 2008, Bruce Hecht and Chase Walker formed MEDS World, LLC, launching innovative odor elimination, exterior plastic trim and headlight restoration products to the Automotive, RV and Marine industries. Bruce and Chase have combined over fifty years of management experiences, in a myriad of indus...

New Probiotics Bacteria Supplier ProbioFerm, LLC Provides the Highest Quality Beneficial Bacteria Available for Product Development

Although recently established, new Probiotics bacteria supplier ProbioFerm, LLC pulls from a thoroughly experienced team to provide the highest possible quality bacteria available. The unique private label manufacturing company serves animal feed and agriculture businesses, functioning as a valu...

Helix BioPharma Announces Q3 2009 Financial Results and Provides Product Development Update

AURORA, Ontario, June 15 /PRNewswire/ -- Helix BioPharma Corp. ("Helix" or the "Company"), (TSX, FSE: "HBP") today announced its product development progress, quarterly highlights and financial results for the third quarter of fiscal 2009, ended April 30, 2009. THIRD QUARTER HIGHLIGHTS AND P...

NeurogesX Provides U.S. Regulatory Update for Qutenza(TM)

20-Patient Study to Evaluate FDA-Approved Topical Anesthetic Pretreatment SAN MATEO, Calif., June 10 /PRNewswire-FirstCall/ -- NeurogesX, Inc. (Nasdaq: NGSX ) announced today that the U.S. Food and Drug Administration (FDA) agreed to its proposed study to evaluate Qutenza(TM) in patients w...

PDL BioPharma Provides Second Quarter 2009 Revenue Guidance of Approximately $125 Million

INCLINE VILLAGE, Nev., June 8 /PRNewswire-FirstCall/ -- PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI ) today announced revenue guidance for the second quarter ended June 30, 2009 of approximately $125 million, as compared with $106 million for the second quarter of 2008. The increase is due pr...

Cimzia(R) (certolizumab pegol) Provides Long-Term Remission and Response Rates in Infliximab-Refractory Crohn's Patients

Cimzia(R) shows duration of response up to week 26 in moderate to severe Crohn's patients who failed the intravenous infusion treatment infliximab. CHICAGO, June 1 /PRNewswire/ -- New data from the WELCOME study presented by UCB at the Digestive Disease Week meeting demonstrate that Cimzia(R)...

OncoGenex Pharmaceuticals Announces OGX-011 Treatment Provides Survival Benefit in Randomized Phase 2 Trial in Advanced Metastatic Prostate Cancer

Webcast at 7:10 p.m. Eastern Time Today BOTHELL, WA, and VANCOUVER, May 30 /PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI ) today announced the final results of a Randomized Phase 2 Trial presented during an oral presentation at the American Society of Clinical Oncol...

Reorganizational Healing Provides Access to Greater Quality of Life, Reduced Stress

Model provides way of integrating and sustaining positive change, increasing wellness WASHINGTON, May 28 /PRNewswire-USNewswire/ -- In today's uncertain times, increased stress can wreak havoc on a body's systems. Now, a new emerging wellness, growth and behavioral change paradigm helps indiv...

Cumberland Pharmaceuticals Provides Hospital In-Service Webcast for Acetadote(R)

NASHVILLE, Tenn., May 18 /PRNewswire/ -- Cumberland Pharmaceuticals announced today the launch of an online in-service program for hospitals using Acetadote (acetylcysteine) Injection , the company's intravenous treatment for acetaminophen overdose. (Photo: http://www.newscom.com/cgi-...

Resverlogix Provides Quarterly Update

Alzheimer's disease biomarker assessment to be added to the Phase 1b/2a trial TSX Exchange Symbol: RVX CALGARY, April 28 /PRNewswire-FirstCall/ - Resverlogix Corp. ("Resverlogix" or "Company") (TSX:RVX) is pleased to provide a corporate update on activities as well as an interi...

China Sky One Medical, Inc. Provides Update on Filing Form 10-K

HARBIN, China, April 7 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") (Nasdaq: CSKI ), a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People's Republic of China ("PRC"), today announced that an ...

Amylin Pharmaceuticals Provides Shareholders with Update Regarding Recent Developments

SAN DIEGO, April 2 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ) today released the following letter from its Lead Independent Director, James N. Wilson, providing shareholders with an update on recent developments: Dear Fellow Amylin Shareholder: As Lead Indep...

US Oncology Provides Full Service Management of Clinical Trials

HOUSTON, April 2 /PRNewswire/ -- US Oncology , the nation's foremost cancer treatment and research network, has established US Oncology Clinical Development (USOCD), a full service contract research organization (CRO). USOCD formalizes many of the services that US Oncology Resear...

SemBioSys provides update on insulin program

CALGARY, April 1 /PRNewswire-FirstCall/ - SemBioSys Genetics Inc. (TSX:SBS), specializing in the manufacture of high-value proteins and oils in plant seeds, provides an update on its proprietary plant-produced recombinant human insulin program. In December 2008, SemBioSys announced that MannKind C...

Cochlear Americas Provides Support for Cochlear Implant Recipients to Pursue Higher Education

Company Announces 2009 Graeme Clark Scholarship Winners DENVER, March 30 /PRNewswire/ -- Cochlear Americas, the world's leader in advanced hearing technologies, today announced the winners of the 2009 Graeme Clark Scholarship awards. Since 2002, the Graeme Clark Cochlear Scholarship Foundatio...

Nile Therapeutics Provides Update on Phase II CD-NP Clinical Trial for Acute Heart Failure

SAN FRANCISCO, March 27 /PRNewswire-FirstCall/ -- Nile Therapeutics, Inc. (Nasdaq: NLTX ), a leading company in the development of novel therapeutics for heart failure patients, announced today that, in the course of reviewing the Investigational New Drug (IND) application materials that Nile ...

Medivation Reports Fourth Quarter and Year-End 2008 Financial Results and Provides Corporate Update

- Conference Call Today at 4:30 p.m. Eastern Time - SAN FRANCISCO, March 16 /PRNewswire-FirstCall/ -- Medivation, Inc. (Nasdaq: MDVN ) today reported on its corporate progress and financial results for the fourth quarter and year ended December 31, 2008. "We had a very productive ...

Biogenerics Legislation Provides Critical Pathway to Affordable Access for Patients with Chronic and Complex Conditions

WASHINGTON, March 12 /PRNewswire-FirstCall/ -- Proposed legislation that creates a regulatory framework to guide the approval of the first biogeneric medicines represents a critical step forward in providing more affordable treatment for millions of Americans suffering from chronic and complex con...

OncoGenex Reports Financial Results for Fourth Quarter and Fiscal Year 2008 and Provides Outlook for 2009

Conference Call on Wednesday, March 11, 2009 at 4:30 p.m. Eastern Time BOTHELL, WA, and VANCOUVER, March 11 /PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals, Inc. ("OncoGenex" or the "Company") (NASDAQ: OGXI ), today announced its fourth quarter and fiscal year 2008 financial results, rev...

FDA Provides A Positive Review of InNexus Biotechnology Development Plan for Lead Product

- Agency Supports Company's Production and Clinical and Preclinical Plans for DXL625 - - Live Teleconference Scheduled with Leadership and Scientific Team for March 04, 2009 - BRITISH COLUMBIA, Canada March 3 /PRNewswire-FirstCall/ -- InNexus Biotechnology Inc. (Toronto Stock Exchange: ...

In Analyst Interview, Cord Blood America Provides Details of Special Shareholder Meeting

SANTA MONICA, Calif., Feb. 20 /PRNewswire-FirstCall/ -- Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company ( http://www.cordblood-america.com ) focused on bringing the life saving potential of stem cells to families nationwide and internati...

Zogenix Reports FDA Provides New PDUFA Date for Sumavel(TM) DosePro(TM)

SAN DIEGO, Feb. 18 /PRNewswire/ -- Zogenix, Inc. ("Zogenix"), a private, specialty pharmaceutical company, announced that the U.S. Food & Drug Administration (FDA) has provided a target date of July 15, 2009 for completion of its review of the NDA for Sumavel DosePro (sumatriptan injection...

Sigma-Aldrich (Nasdaq: SIAL) Reports Fourth Quarter Diluted EPS of $0.68. Ends 2008 With Record Sales and Earnings and Raises Quarterly Cash Dividend by 11.5%. Provides Outlook for 2009.

ST LOUIS, Feb. 11 /PRNewswire-FirstCall/ -- Sigma-Aldrich, a leading Life Science and High Technology company, reported that its fourth quarter 2008 diluted EPS grew by 6% to $0.68 from $0.64 in the same quarter of 2007. Reported sales of $510 million in the fourth quarter 2008 declined...

ADVENTRX Provides Update on Strategic Transaction Process

SAN DIEGO, Feb. 10 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Alternext US: ANX) announced today that it has received written indications of interest from numerous companies representing a range of strategic transactions. The Company currently is evaluating all proposals a...

BioCryst Reports Fourth Quarter and Year End 2008 Financial Results and Provides Corporate Update

BIRMINGHAM, Ala., Feb. 6 /PRNewswire-FirstCall/ -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX ) today announced financial results for the fourth quarter and year ended December 31, 2008. Fourth Quarter 2008 Financial Results For the three months ended December 31, 2008, the Compan...

New Study Provides Benchmarks for Optimizing Marketing Staff Levels to Drive Growth

CHAPEL HILL, N.C., Feb. 5 /PRNewswire/ -- In today's tough economy, maintaining operational efficiencies remains key, even while focusing on strategy and tactics to drive growth and profitability. In an effort to better understand the resources dedicated by biopharmaceutical companies to supp...

OncoGenex Provides Update on Two-Year Survival Data from Ongoing Phase 1/2 Clinical Trial of OGX-011 in Non-Small Cell Lung Cancer

BOTHELL, WA, and VANCOUVER, Feb. 4 /PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI ) today announced the two-year survival rate from a Phase 1/2 clinical trial of OGX-011 in combination with first-line chemotherapy for the treatment of advanced non-small cell lung cancer (...

Bluegiga Provides Health Device Profile for its Bluetooth OEM Modules

CONTINUA WINTER SUMMIT and TOKYO, February 4 /PRNewswire/ -- Bluegiga announced today that its OEM Bluetooth modules are now available with Bluetooth Health Device Profile (HDP). The Health Device profile is integrated into Bluegiga's iWRAP firmware, running inside the Bluegiga module, signifi...

Genomic Health Announces Fourth Quarter and Year-End 2008 Financial Results and Business Progress, Provides 2009 Financial Guidance

REDWOOD CITY, Calif., Feb. 3 /PRNewswire-FirstCall/ -- Genomic Health, Inc. (Nasdaq: GHDX ) today reported financial results and business progress for the fourth quarter and year ended December 31, 2008. Total revenue for the fourth quarter of 2008 increased to $31.2 million, compared...

Vasogen Announces Sale of Patent Application and Provides Corporate Update

MISSISSAUGA, ON, Feb. 2 /PRNewswire-FirstCall/ - Vasogen Inc. (NASDAQ: VSGN ; TSX:VAS) today announced that it has sold a United States patent application and its related foreign counterparts for US$400,000. This device-based intellectual property has not been used to date in the Celacade System;...

New Study Provides Benchmarks for Winning Brand Team Management

CHAPEL HILL, N.C., Jan. 30 /PRNewswire/ -- New research has illustrated the dramatic impact effective structuring of brand teams can have on the success of pharmaceutical product sales before and after launch. In an effort to better understand the best practices in developing effective brand team...

CuraGen Reports Fourth Quarter 2008 Financial Results; Provides Milestone and Financial Guidance for First Half of 2009

BRANFORD, Conn., Jan. 29 /PRNewswire-FirstCall/ -- CuraGen Corporation (Nasdaq: CRGN ), today reported its financial results for the fourth quarter and calendar year of 2008 and provided milestone and financial guidance for the first half of 2009. During the three month period ended December...
Other Tags
(Date:7/27/2014)... -- Microorganisms like bacteria and fungi can evade treatment ... or antifungal drugs. These permanent mutations were once thought ... evolve. Now a new study has shown that microorganisms ... known as epimutations -- to gain the benefits of ... mechanism was discovered in a fungus called Mucor circinelloides, ...
(Date:7/27/2014)... age of "big data," a single computer cannot always ... instead be distributed across a cluster of computers that ... and Google mine your web history to present you ... your next favorite book or movie. But big data ... technologies for monitoring brain activity are generating unprecedented quantities ...
(Date:7/25/2014)... 100,000s of people lived on the land now called ... control the availability of plants they used for food, ... fire to maintain desired habitat and natural resources. , ... Pacific Southwest Station, will lead a field trip ... the Ecological Society of America,s 99th Annual Meeting, in ...
Breaking Biology News(10 mins):Scientists discover new, noncommittal mechanism of drug resistance 2Scientists discover new, noncommittal mechanism of drug resistance 3New tools help neuroscientists analyze 'big data' 2New tools help neuroscientists analyze 'big data' 3New tools help neuroscientists analyze 'big data' 4New tools help neuroscientists analyze 'big data' 5Fire ecology manipulation by California native cultures 2Fire ecology manipulation by California native cultures 3
(Date:7/28/2014)... St. Jude Children’s Research Hospital has ... Defense Employer Support Freedom Award from the Employer Support of ... The award is the highest honor given by the U.S. ... serve in the National Guard and Reserve. , “We deeply ... contributions to the St. Jude mission and to our country,” ...
(Date:7/28/2014)... (PRWEB) July 28, 2014 The ... the majority of professionals engaged in the field ... the Transplantation and Immunology Research Network ... and immunology research. As modern organ transplantation continues ... network that could provide more opportunities for physicians, ...
(Date:7/28/2014)... BEER-SHEVA, ISRAEL, July 28, 2014...Mothers who live near ... weights, according to a new study, "Green Spaces ... Occupational and Environmental Medicine . , A ... Ben-Gurion University of the Negev (BGU), evaluated nearly ... cohort in Tel Aviv, Israel to determine the ...
(Date:7/28/2014)... into improving treatment for patients with one of the ... funding boost. , Chronic obstructive pulmonary disease (COPD) is ... breathing difficulties due to long-term damage to the lungs. ... 10 per cent of all hospital admissions in the ... to hospital after they are discharged. , ...
(Date:7/28/2014)... findings made possible by a test developed at University ... (CU School of Pharmacy), AURORA, Colo (July 28, 2014) ... Colorado Antiviral Pharmacology Laboratory at the CU School of ... drug called Truvada (a combination of tenofovir/emtricitabine), which is ... A study presented during the AIDS 2014 Conference and ...
Breaking Medicine News(10 mins):Health News:St. Jude Children’s Research Hospital Receives Secretary of Defense Employer Support Freedom Award 2Health News:St. Jude Children’s Research Hospital Receives Secretary of Defense Employer Support Freedom Award 3Health News:American Society of Transplantation (AST) Launches Transplantation and Immunology Research Network (TIRN); Aims to Expand Research Collaboration & Funding 2Health News:American Society of Transplantation (AST) Launches Transplantation and Immunology Research Network (TIRN); Aims to Expand Research Collaboration & Funding 3Health News:New research to tackle treatment for lung disease 2Health News:New research to tackle treatment for lung disease 3Health News:HIV research findings made possible by a test developed at CU School of Pharmacy 2
Other Contents